Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,794,549
  • Shares Outstanding, K 209,399
  • Annual Sales, $ 7,410 K
  • Annual Income, $ -166,410 K
  • 60-Month Beta 0.66
  • Price/Sales 243.84
  • Price/Cash Flow N/A
  • Price/Book 3.19
Trade INO with:

Options Overview

Details
  • Implied Volatility 100.81%
  • Historical Volatility 75.49%
  • IV Percentile 9%
  • IV Rank 10.36%
  • IV High 279.67% on 06/25/20
  • IV Low 80.13% on 05/26/21
  • Put/Call Vol Ratio 0.25
  • Today's Volume 14,169
  • Volume Avg (30-Day) 19,216
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 207,955
  • Open Int (30-Day) 210,523

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.26
  • Number of Estimates 5
  • High Estimate -0.20
  • Low Estimate -0.34
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -13.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.72 +31.25%
on 05/19/21
10.33 -14.62%
on 06/09/21
+2.02 (+29.71%)
since 05/17/21
3-Month
5.81 +51.81%
on 05/11/21
10.50 -16.00%
on 03/18/21
-1.70 (-16.16%)
since 03/17/21
52-Week
5.81 +51.81%
on 05/11/21
33.79 -73.90%
on 06/26/20
-5.00 (-36.18%)
since 06/17/20

Most Recent Stories

More News
Should You Buy Biotech ETFs Now?

Biotech stocks are rallying this month; can the trend continue?

BIIB : 383.52 (-1.99%)
AMGN : 240.76 (+0.49%)
GILD : 67.22 (-0.16%)
MRNA : 202.47 (+2.34%)
IBB : 159.06 (+0.49%)
INO : 8.82 (+2.92%)
XBI : 134.38 (+0.59%)
CLOV : 12.56 (-3.01%)
IBBQ : 25.16 (+0.76%)
Thinking about buying stock in Sellas Life Sciences, ContextLogic, Corsair Gaming, Inovio Pharmaceuticals, or The GEO Group?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SLS, WISH, CRSR, INO, and GEO.

CRSR : 33.06 (-0.90%)
INO : 8.82 (+2.92%)
SLS : 11.46 (+0.61%)
WISH : 11.23 (+1.26%)
GEO : 7.20 (-1.37%)
INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate, INO-4800

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated...

INO : 8.82 (+2.92%)
New Strong Sell Stocks for June 7th

AL, FET, INO, SWKH, and WPG have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2021.

AL : 43.83 (-3.29%)
INO : 8.82 (+2.92%)
WPG : 2.49 (-6.74%)
FET : 23.49 (-0.42%)
SWKH : 16.98 (-0.24%)
Geneos Therapeutics Announces Clinical Updates on Personalized Cancer Vaccine Program

, /PRNewswire/ -- Geneos Therapeutics, a clinical stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer, announced today positive preliminary results...

INO : 8.82 (+2.92%)
INOVIO to Present at the Jefferies 2021 Virtual Healthcare Conference

, /PRNewswire/ -- INOVIO (NASDAQ:INO) a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated...

INO : 8.82 (+2.92%)
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated...

GILD : 67.22 (-0.16%)
INO : 8.82 (+2.92%)
Vaccines Market Size 2021 | Is Projected to Reach USD 104.87 Billion by 2027, Exhibiting a CAGR of 10.7 %

The global business vaccines market share is projected to reach USD 104.87 billion by 2027, exhibiting a CAGR of 10.7 % during the forecast period due to rise in infectious diseases observes, Fortune Business...

CSLLY : 114.9600 (-1.09%)
INO : 8.82 (+2.92%)
MRK : 77.23 (+0.81%)
NVS : 94.15 (+0.38%)
PFE : 39.48 (+0.46%)
INOVIO's Pan-COVID-19 Vaccine Candidate (INO-4802) Induces Broad Immunity Against Major Viral Variants in Preclinical Studies

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated...

INO : 8.82 (+2.92%)
Zika Virus Vaccines Market Size, Share, Trends, Analysis and Forecast 2027

The report on Zika Virus Vaccines provides the clients with a comprehensive analysis of crucial driving factors, consumer behavior, growth trends, product utilization, key player analysis, brand positioning...

CERS : 5.90 (+2.79%)
GSK : 40.57 (-0.22%)
IMV.TO : 2.94 (+1.38%)
INO : 8.82 (+2.92%)
XON : 4.65 (-4.12%)
NLNK : 0.8900 (-12.75%)
TKPYY : 16.5900 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 9.21
2nd Resistance Point 9.00
1st Resistance Point 8.78
Last Price 8.82
1st Support Level 8.35
2nd Support Level 8.14
3rd Support Level 7.92

See More

52-Week High 33.79
Fibonacci 61.8% 23.10
Fibonacci 50% 19.80
Fibonacci 38.2% 16.50
Last Price 8.82
52-Week Low 5.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar